6. Secondary immunodeficiencies, including HIV infection

Journal of Allergy and Clinical Immunology

Volumn 121, Issue 2 SUPPL. 2, 2008, Pages

  Chinen, Javier ^a   Shearer, William T ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

AIDS; immunosuppression; lymphopenia; Secondary immunodeficiency

Indexed keywords

ABACAVIR; ANTIRETROVIRUS AGENT; CORTICOSTEROID; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADAPTIVE IMMUNITY; ALTITUDE; ARTHRALGIA; ARTICLE; DIABETES MELLITUS; DIARRHEA; DRUG WITHDRAWAL; ENVIRONMENTAL FACTOR; FEVER; HEREDITY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPOXIA; IMMUNE DEFICIENCY; IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNOPATHOGENESIS; IMMUNOSUPPRESSIVE TREATMENT; INFECTION; INNATE IMMUNITY; IONIZING RADIATION; MALNUTRITION; METABOLIC DISORDER; MULTIORGAN HYPERSENSITIVITY; MYALGIA; PRIORITY JOURNAL; PROTEIN CALORIE MALNUTRITION; RASH; SPACE FLIGHT; STEVENS JOHNSON SYNDROME; SURGICAL TECHNIQUE; ULTRAVIOLET RADIATION; UNSPECIFIED SIDE EFFECT; UREMIA; VIROLOGY;

ANTIBODY FORMATION; DIABETES COMPLICATIONS; ENVIRONMENT; HIV INFECTIONS; HUMANS; IMMUNOLOGIC DEFICIENCY SYNDROMES; MALNUTRITION; SURGICAL PROCEDURES, OPERATIVE; UREMIA; WOUNDS AND INJURIES;

EID: 38649092020     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaci.2007.06.003     Document Type: Article

References (25)

1. Bonilla F.A., and Geha R.S. Update in primary immunodeficiency diseases. J Allergy Clin Immunol 117 (2006) S435-S441
2. In: Stiehm E.R., Ochs H.D., and Wilkenstein J.A. (Eds). Immunologic disorders in infants and children. 3rd ed. (2004), Elsevier Saunders, Philadelphia (PA)
3. In: Rich R.R., Fleisher T.A., Shearer W.T., Kotzin B.L., and Schroeder H.W. (Eds). Clinical immunology: principles and practice. 2nd ed. (2001), Mosby, London
4. Tan H.P., Smaldone M.C., and Shapiro R. Immunosuppressive preconditioning or induction regimens, evidence to date. Drugs 66 (2006) 1535-1545
5. Pawelec G., Koch S., Franceschi C., and Wikby A. Human immunosenescence: does it have an infectious component?. Ann N Y Acad Sci 1067 (2006) 56-65
6. Cunningham-Rundles, McNeeley D.F., and Moon A. Mechanisms of nutrient modulation of the immunoresponse. J Allergy Clin Immunol 115 (2005) 1119-1128
7. Douglas S.D. Down syndrome: immunologic and epidemiologic associations-enigmas remain. J Pediatr 147 (2005) 723-725
8. Shearer W.T., Zhang S., Reuben J.M., Lee B.M., and Butel J.S. Effects of radiation and latent virus on immune responses in a space flight model. J Allergy Clin Immunol 115 (2005) 1297-1303
9. Sleasman J.W., and Goodenow M.M. HIV-1 infection. J Allergy Clin Immunol 111 (2003) 582-592
10. UNAIDS. AIDS pandemic update: special report on HIV/AIDS: December 2006. Geneva, Switzerland: Joint United Nations Programme on HIV/AIDS (UNAIDS) and World Health Organization (WHO); 2006.
11. Center for Disease Control and Prevention. HIV/AIDS surveillance report. Vol 18 (2005), Department of Health and Human Services, Atlanta (GA)
12. Goodenow M.M., and Collman R.G. HIV-1 coreceptor is distinct from viral tropism: a dual-parameter nomenclature to define viral phenotypes. J Leukoc Biol 80 (2006) 965-972
13. Harris R.S., and Liddament M.T. Retroviral restriction by APOBEC proteins. Nat Rev Immunol 4 (2004) 868-877
14. Brenchley J.M., Schacker T.W., Ruff L.E., Price D.A., Taylor J.H., Beilman G.J., et al. CD4+ T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract. J Exp Med 200 (2004) 749-759
15. Norris P.J., Pappalardo B.L., Custer B., Spotts G., Hecht F.M., Busch M.P., et al. Elevations in IL-10, TNF-alpha, and IFN-gamma from the earliest point of HIV Type 1 infection. AIDS Res Hum Retroviruses 22 (2006) 757-762
16. Espert L., Denizot M., Grimaldi M., Robert-Hebmann V., Gay B., Varbanov M., et al. Autophagy is involved in T cell death after binding of HIV-1 envelope proteins to CXCR4. J Clin Invest 116 (2006) 2161-2172
17. Rodriguez B., Sethi A.K., Cheruvu V.K., Mackay W., Bosch R.J., Kitahata M., et al. Predictive value of plasma HIV RNA level on rate of CD4 T-cell decline in untreated HIV infection. JAMA 296 (2006) 1498-1506
18. Paul M.E., Mao C., Charurat M., Serchuck L., Foca M., Hayani K., et al. Predictors of immunologic long-term nonprogression in HIV-infected children: implications for initiating therapy. J Allergy Clin Immunol 115 (2005) 848-855
19. Panel on Antiretroviral Guidelines for Adult and Adolescents. Guidelines for the use of antiretroviral agents in HIV-infected adults and adolescents. Department of Health and Human Services. October 10, 2006. Available at: http://www.aidsinfo.nih.gov/ContentFiles/AdultandAdolescentsGL.pdf. Accessed April 30, 2007.
20. Stoll M., and Schmidt R.E. Adverse events of desirable gain in immunocompetence: the immune restoration inflammatory syndromes. Autoimmun Rev 3 (2004) 243-249
21. Working Group on Antiretroviral Therapy and Medical Management of HIV-Infected Children. Guidelines for the use of antiretroviral agents in pediatric HIV infection. October 26, 2006. Available at: http://aidsinfo.nih.gov/ContentFiles/PediatricGuidelines.pdf. Accessed April 30, 2007.
22. McMichael A. HIV vaccines. Annu Rev Immunol 24 (2006) 227-255
23. Lederman M.M., Offord R.E., and Hartley O. Microbicides and other topical strategies to prevent vaginal transmission of HIV. Nat Rev Immunol 6 (2006) 371-382
24. Cohen J. Hope on new AIDS drugs, but breast-feeding strategy backfires. Science 315 (2007) 1357
25. Newell M.L., and Barninghausen T. Male circumcision to cut HIV risk in the general population. Lancet 369 (2007) 617-618